These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 23824605)

  • 1. TMEFF2 and SARDH cooperate to modulate one-carbon metabolism and invasion of prostate cancer cells.
    Green T; Chen X; Ryan S; Asch AS; Ruiz-Echevarría MJ
    Prostate; 2013 Oct; 73(14):1561-75. PubMed ID: 23824605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The tumor suppressor activity of the transmembrane protein with epidermal growth factor and two follistatin motifs 2 (TMEFF2) correlates with its ability to modulate sarcosine levels.
    Chen X; Overcash R; Green T; Hoffman D; Asch AS; Ruiz-Echevarría MJ
    J Biol Chem; 2011 May; 286(18):16091-100. PubMed ID: 21393249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of sarcosine metabolism in prostate cancer progression.
    Khan AP; Rajendiran TM; Ateeq B; Asangani IA; Athanikar JN; Yocum AK; Mehra R; Siddiqui J; Palapattu G; Wei JT; Michailidis G; Sreekumar A; Chinnaiyan AM
    Neoplasia; 2013 May; 15(5):491-501. PubMed ID: 23633921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The TMEFF2 tumor suppressor modulates integrin expression, RhoA activation and migration of prostate cancer cells.
    Chen X; Corbin JM; Tipton GJ; Yang LV; Asch AS; Ruiz-Echevarría MJ
    Biochim Biophys Acta; 2014 Jun; 1843(6):1216-24. PubMed ID: 24632071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alteration of the tumor suppressor SARDH in sporadic colorectal cancer: A functional and transcriptome profiling-based study.
    He H; Chen E; Lei L; Yan B; Zhao X; Zhu Z; Li Q; Zhang P; Zhang W; Xing J; Du L; Dong J; Yang J
    Mol Carcinog; 2019 Jun; 58(6):957-966. PubMed ID: 30693981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implications of differences in expression of sarcosine metabolism-related proteins according to the molecular subtype of breast cancer.
    Yoon JK; Kim DH; Koo JS
    J Transl Med; 2014 May; 12():149. PubMed ID: 24884785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of TMEFF2 in Human Pancreatic Cancer Tissue and the Effects of TMEFF2 Knockdown on Cell, Proliferation, and Apoptosis in Human Pancreatic Cell Lines.
    Li K; Gu W; Xu J; Wang A; Han H
    Med Sci Monit; 2019 May; 25():3238-3246. PubMed ID: 31044775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phorbol ester-induced shedding of the prostate cancer marker transmembrane protein with epidermal growth factor and two follistatin motifs 2 is mediated by the disintegrin and metalloproteinase-17.
    Ali N; Knaüper V
    J Biol Chem; 2007 Dec; 282(52):37378-88. PubMed ID: 17942404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of TMEFF2 allografts and transgenic mouse models reveals roles in prostate regeneration and cancer.
    Corbin JM; Overcash RF; Wren JD; Coburn A; Tipton GJ; Ezzell JA; McNaughton KK; Fung KM; Kosanke SD; Ruiz-Echevarria MJ
    Prostate; 2016 Jan; 76(1):97-113. PubMed ID: 26417683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A truncated isoform of TMEFF2 encodes a secreted protein in prostate cancer cells.
    Quayle SN; Sadar MD
    Genomics; 2006 May; 87(5):633-7. PubMed ID: 16439095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Androgen signaling promotes translation of TMEFF2 in prostate cancer cells via phosphorylation of the α subunit of the translation initiation factor 2.
    Overcash RF; Chappell VA; Green T; Geyer CB; Asch AS; Ruiz-Echevarría MJ
    PLoS One; 2013; 8(2):e55257. PubMed ID: 23405127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TMEFF2 shedding is regulated by oxidative stress and mediated by ADAMs and transmembrane serine proteases implicated in prostate cancer.
    Gaweł-Bęben K; Ali N; Ellis V; Velasco G; Poghosyan Z; Ager A; Knäuper V
    Cell Biol Int; 2018 Mar; 42(3):273-280. PubMed ID: 28762604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brucine Suppresses Malignant Progression of Prostate Cancer by Decreasing Sarcosine Accumulation via Downregulation of GNMT in the Glycine/sarcosine Metabolic Pathway.
    Miao L; Liu Y; Chen W; Gao C; Zhang Y; Wei J; Cao X
    Cell Biochem Biophys; 2024 Sep; 82(3):2373-2385. PubMed ID: 38877335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repression of the TMEFF2 promoter by c-Myc.
    Gery S; Koeffler HP
    J Mol Biol; 2003 May; 328(5):977-83. PubMed ID: 12729735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TMEFF2 is an androgen-regulated gene exhibiting antiproliferative effects in prostate cancer cells.
    Gery S; Sawyers CL; Agus DB; Said JW; Koeffler HP
    Oncogene; 2002 Jul; 21(31):4739-46. PubMed ID: 12101412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A TMEFF2-regulated cell cycle derived gene signature is prognostic of recurrence risk in prostate cancer.
    Georgescu C; Corbin JM; Thibivilliers S; Webb ZD; Zhao YD; Koster J; Fung KM; Asch AS; Wren JD; Ruiz-Echevarría MJ
    BMC Cancer; 2019 May; 19(1):423. PubMed ID: 31060542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression.
    Sreekumar A; Poisson LM; Rajendiran TM; Khan AP; Cao Q; Yu J; Laxman B; Mehra R; Lonigro RJ; Li Y; Nyati MK; Ahsan A; Kalyana-Sundaram S; Han B; Cao X; Byun J; Omenn GS; Ghosh D; Pennathur S; Alexander DC; Berger A; Shuster JR; Wei JT; Varambally S; Beecher C; Chinnaiyan AM
    Nature; 2009 Feb; 457(7231):910-4. PubMed ID: 19212411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preclinical validation of anti-TMEFF2-auristatin E-conjugated antibodies in the treatment of prostate cancer.
    Afar DE; Bhaskar V; Ibsen E; Breinberg D; Henshall SM; Kench JG; Drobnjak M; Powers R; Wong M; Evangelista F; O'Hara C; Powers D; DuBridge RB; Caras I; Winter R; Anderson T; Solvason N; Stricker PD; Cordon-Cardo C; Scher HI; Grygiel JJ; Sutherland RL; Murray R; Ramakrishnan V; Law DA
    Mol Cancer Ther; 2004 Aug; 3(8):921-32. PubMed ID: 15299075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bidirectional regulation between TMEFF2 and STAT3 may contribute to Helicobacter pylori-associated gastric carcinogenesis.
    Sun TT; Tang JY; Du W; Zhao HJ; Zhao G; Yang SL; Chen HY; Hong J; Fang JY
    Int J Cancer; 2015 Mar; 136(5):1053-64. PubMed ID: 24996057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TMEFF2 is a novel prognosis signature and target for endometrial carcinoma.
    Gao L; Nie X; Zheng M; Li X; Guo Q; Liu J; Liu Q; Hao Y; Lin B
    Life Sci; 2020 Feb; 243():116910. PubMed ID: 31610211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.